
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Arnav Srivastava is an urologic oncology fellow at the University of Michigan. He obtained his MD, MPH from The Johns Hopkins University School of Medicine in Baltimore, MD. He then completed his urology residency at Rutgers Robert Wood Johnson University Hospital in New Brunswick, NJ.
He has clinical interests in urologic malignancies including prostate, bladder, and kidney cancer.
He has research interests in health services research, health economics, insurance design, and biomarker development.
He has more than 50 publications and over 1000 citings.
Education & Training
- University of Michigan Health SystemFellowship, Urologic Surgical Oncology, 2023 - 2026
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2018 - 2023
- Johns Hopkins University School of MedicineClass of 2017
Certifications & Licensure
- MI State Medical License 2023 - 2026
- NJ State Medical License 2019 - 2025
Publications & Presentations
PubMed
- Trends in Surgical Overtreatment of Prostate Cancer.Steven M Monda, Timothy Demus, Salvador Jaime-Casas, Sabir Meah, Arnav Srivastava
JAMA Oncology. 2025-04-28 - Rethinking the definition of stage III disease in adrenocortical carcinoma: Assessing the impact of clinical lymph node positive disease.Benjamin J Lichtbroun, Helen Gao, Kevin Chua, John Pfail, Rachel Passarelli
Urologic Oncology. 2025-04-01 - Editorial Comment.Kristin Weiss, Arnav Srivastava
The Journal of Urology. 2025-03-27
Press Mentions
- Implant Shows Promise for Tumor-Specific Treatment in Prostate CancerFebruary 5th, 2025
- Financial Incentive Did Not Increase Prostate Cancer Active Surveillance AdoptionJanuary 14th, 2025
- Payment Incentives Fail to Push Physicians Toward MRI Surveillance of Low-Risk Prostate CancerJanuary 10th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: